does semaglutide cause allodynia In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist in 5-23% of recipients GLP-1 Drugs: New Reports of

The data also indicates potential applications for addressing age-related cognitive decline, though higher doses may be necessary in older populations to achieve optimal benefits

In contrast, slightly larger PET MPs (100150 m

Therefore, no effect of empagliflozin is anticipated on concomitantly administered drugs that are substrates of the major CYP450 isoforms or UGT1A1, UGT1A3, UGT1A8, UGT1A9, or UGT2B7

Funding This study was funded by the High Level Chinese Medical Hospital Promotion Project (HLCMHPP2023089), the Special Programme for the Cultivation of Outstanding Young Scientific and Technological Talents (Innovation Category) under the Basic Scientific Research Fund of China Academy of Chinese Medical Sciences (ZZ13-YQ-019), and the Fundamental Research Funds for the Central Public Welfare Research Institutes (ZZ-YQ2023004)